Abstract:OBJECTIVE:To investigate part mechanisms of Th cell differentiation, and to observe the interference effect of Qingxin-II Recipe in the chronic stage of viral myocarditis (VMC), so as to provide some experimental evidences for illuminating the pathogenesis of VMC and treatment mechanisms of Qingxin-II Recipe. METHODS:According to 20%-40% death rate of experiment in advance, 100 BALB/c male mice (4 weeks old and weighing 12-15 g) were used. Twenty mice were randomly assigned to normal control group, and the other 80 mice were intraperitoneally injected with 0.1 ml normal saline containing coxsackie virus B3 at the 1st, 4th and 28th day (the virus densities were 1:2000, 1:1000 and 1:500 respectively) to induce chronic VMC. At the 42nd day, the surviving mice were randomly divided into untreated group and treatment group, with 20 mice in each group. Mice in the treatment group were orally administered with 0.2 ml Qingxin-II Recipe every day, while mice in the normal control group and the untreated group were administered with 0.2 ml normal saline. All the mice were sacrificed after 45 days, and the sera, heart and spleen cells were collected. Then the myocardial pathological changes were observed by using a light microscope, and the levels of IL-4, IL-10 and IFN-gamma in serum were detected by enzyme linked immunosorbent assay (ELISA). And the Th cell differentiation was observed by flow cytometry. RESULTS:No obvious myocardial pathological changes were observed in mice of the normal control group. Myocardial pathological changes in the treatment group were slighter than those in the untreated group. The difference of serum IL-10 level between the normal control group and the untreated group showed no significance (P>0.05), and the levels of IFN-gamma and IL-4 of the untreated group were higher than those of the normal control group (P<0.05 or P<0.01). There was no statistical difference in IL-10 level between the treatment group and the untreated group (P>0.05), while the serum levels of IL-4 and IFN-gamma of the treatment group were lower than those of the untreated group (P<0.05 or P<0.01). There was no significant difference of the Th1 cell responder between the treatment group and the untreated group (P>0.05), while the Th2 cell responder was inhibited significantly in the treatment group (P<0.05). CONCLUSION:Qingxin-II Recipe can restore the balance of Thl and Th2 cells through inhibiting the reaction of Th2.

Manipulating Intestinal Immunity and Microflora: an Alternative Solution to Viral Myocarditis?

Altered colonic microflora and its metabolic profile in mice with acute viral myocarditis induced by coxsackievirus B3

The Severity of CVB3-Induced Myocarditis Can Be Improved by Blocking the Orchestration of NLRP3 and Th17 in Balb/c Mice

Myocardial Mitochondrial DNA Drives Macrophage Inflammatory Response Through STING Signaling in Coxsackievirus B3-Induced Viral Myocarditis.

Coxsackievirus group B3 regulates ASS1-mediated metabolic reprogramming and promotes macrophage inflammatory polarization in viral myocarditis

Crosstalk Between Innate Immunity and Autophagy in Viral Myocarditis Leading to Dilated Cardiomyopathy

Role of Coxsackievirus B3-Induced Immune Responses in the Transition from Myocarditis to Dilated Cardiomyopathy and Heart Failure

The Communal Pathogenesis, Autophagy Mechanism and Potential Therapeutic Targets in Dilated Cardiomyopathy and Viral Myocarditis

Alterations of the gut microbiome and metabolic profile in CVB3-induced mice acute viral myocarditis

[Th cell differentiation in chronic stage of viral myocarditis in mice and interference of Qingxin-II Recipe].

Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.

Mechanisms and Therapeutic Strategies of Viral Myocarditis Targeting Autophagy

Blocking the CD40-CD40L Interaction by CD40-Ig Reduces Disease Progress in Murine Myocarditis Induced by CVB3.

NMR-Based Metabolomic Analysis of Sera in Mouse Models of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy

Viral myocarditis: From molecular mechanisms to therapeutic prospects

NMR-Based Metabolomic Analysis of Cardiac Tissues Clarifies Molecular Mechanisms of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy

Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue

Influence of Intravenous-Immunoglobulin on T Lymphocyte Subsets, NK Cell and Some Cytokines in Mice with Experimental Viral Myocarditis

The Role of B Cells in Regulation of Th Cell Differentiation in Coxsackievirus B3-Induced Acute Myocarditis

Vγ1+γδT, Early Cardiac Infiltrated Innate Population Dominantly Producing IL-4, Protect Mice Against CVB3 Myocarditis by Modulating IFNγ+ T Response